Several studies suggest that interleukin-17 (IL-17A or IL-17 or cytotoxic T-lymphocyte-associated protein 8) plays a major role in colorectal cancer progression [8–12] and in the resistance to anti-VEGF treatment in murine models [13] or chemotherapy [14, 15]. This evidence concerns the gene VEGFA and colorectal cancer.